Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quest Diagnostics (DGX – Research Report), Synergy CHC (SNYR – Re...

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Synergy CHC (SNYR) and Humana (HUM)

An announcement from Digi Power X ( ($TSE:DGX) ) is now available. Digi Power X announced its participation in the PTC 2026 conference in Honolulu,...

Digi Power X Advances AI Infrastructure Strategy with PTC 2026 Presence and ARMS 200 Rollout

Bernstein analyst Zhihan Ma maintained a Buy rating on Dollar General today and set a price target of $150.00. According to TipRanks, Ma is a 4-sta...

Bernstein Sticks to Their Buy Rating for Dollar General (DG)

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Quest Diagnostics today and set a price target of $190.00. Anderson CFA cov...

Evercore ISI Remains a Hold on Quest Diagnostics (DGX)

Quest Diagnostics ( ($DGX) ) has shared an update. On January 12, 2026, Quest Diagnostics outlined its growth strategy and operational priorities a...

Quest Diagnostics Highlights Growth Strategy at Healthcare Conference

U.S. stocks ended the week higher as investors balanced softer hiring data with new government support for housing and stronger momentum in energy ...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 11

Barclays analyst Seth Sigman maintained a Buy rating on Dollar General today and set a price target of $151.00. Sigman covers the Consumer Cyclical...

Dollar General (DG) Gets a Buy from Barclays

An update from Digi Power X ( ($TSE:DGX) ) is now available. Digi Power X has entered into a non-binding letter of intent with Omnis Pleasants LLC,...

Digi Power X Signs LOI for 1.3 GW Power Plant Partnership to Power AI Infrastructure

Digi Power X ( ($TSE:DGX) ) just unveiled an announcement. Digi Power X reported a 1,150% year-over-year increase in liquidity to approximately $10...

Digi Power X Leverages 1,150% Liquidity Surge to Accelerate Shift into AI Data Centers

In a report released on January 2, Patrick B Donnelly from Citi maintained a Hold rating on Quest Diagnostics. The company’s shares closed last Fri...

Current Quarter	$2.36	Next Quarter	$2.36
Current Year	$9.79	Next Year	$10.41
QoQ Growth	+0.0%	YoY Growth	+6.3%
3Y EPS CAGR	-21.1%	Target Price	$199.47
Consensus	Buy	Upside	+8.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$184.77	-0.13%	431.93K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$184.77	-0.1%	431.93K
3
4
5
6

DGX

DGX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel